4-Aminopyridine improves pulmonary function in quadriplegic humans with longstanding spinal cord injury

Pharmacotherapy

Volumn 17, Issue 3, 1997, Pages 415-423

  Segal, Jack L ^a,b   Brunnemann, Sherry R ^a  

^a VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOPYRIDINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFECT; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INSPIRATORY CAPACITY; MALE; ORAL DRUG ADMINISTRATION; PARAPLEGIA; PEAK EXPIRATORY FLOW; QUADRIPLEGIA; RESPIRATION DEPRESSION; SPINAL CORD INJURY; VITAL CAPACITY;

EID: 0030916531     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1875-9114.1997.tb03051.x     Document Type: Article

References (30)

1. McMichan JC, Michel L, Westbrook PR. Pulmonary function following traumatic quadriplegia. JAMA 1980;243:528-31.
2. Yamasaki M, Komura T, Tahara Y, et al. Peak oxygen uptake and respiratory function in persons with spinal cord injury. Appl Human Sci 1996;15(1):13-17.
3. Black LF, Hyatt RE. Maximal respiratory pressures: normal values and relationship to age and sex. Am Rev Resp Dis 1969;99:696-702.
4. Spungen AM, Dicpinigaitis PV, Almenoff PL, Bauman WA. Pulmonary obstruction in individuals with cervical spinal cord lesions unmasked by bronchodilator administration. Paraplegia 1993;31:404-7.
5. Almenoff PL, Alexander LR, Spungen AM, Lesser MD, Bauman WA. Bronchodilatory effects of ipratropium bromide in patients with tetraplegia. Paraplegia 1995;33:274-7.
6. Bach JR. Indications for tracheostomy and decannulation of tracheostomized ventilator users. Monaldi Arch Chest Dis 1995;50(3):223-7.
7. Fishburn MJ, Marino RJ, Ditunno JF. Atelectasis and pneumonia in acute spinal cord injury. Arch Phys Med Rehabil 1990;71(3):197-200.
8. Bunge RP, Puckett WR, Bercerra JL, Marcillo A, Quencer RM. Observations on the pathology of human spinal cord injury. A review and classification of 22 new cases with details from a case of chronic cord compression with extensive focal demyelination. In: Seil FJ, ed. Advances in neurology, vol 59. New York: Raven Press, 1993:75-89.
9. Hansebout RR, Blight AR, Fawcett S, Reddy K. 4-Aminopyridine in chronic spinal cord injury: a controlled, double-blind, crossover study in eight patients. J Neurotrauma 1993;19:1-18.
10. Hayes KC, Blight AR, Potter PJ, et al. Preclinical trial of 4-aminopyridine in patients with chronic spinal cord injury. Paraplegia 1993;31:216-24.
11. Hayes KC, Potter PJ, Wolfe DL, Hsieh JTC, Delaney GA, Blight AR. 4-Aminopyridine-sensitive neurologic deficits in patients with spinal cord injury. J Neurotrauma 1994;11(4): 433-46.
12. Blight AR, Toombs JP, Bauer MS, Widmer WR. The effects of 4-aminopyridine on neurologic deficits in chronic cases of traumatic spinal cord injury in dogs: a phase I clinical trial. J Neurotrauma 1991;8:103-9.
13. Blight AR, Gruner JA. Augmentation by 4-aminopyridine of vestibulospinal free fall responses in chronic spinal-injured cats. J Neurol Sci 1987;87:145-59.
14. Potter PJ, Hayes KC, Delaney GA, Hsieh JTC, Segal JL. Sustained improvements in neurological function in spinal cord injured patients treated with oral 4-aminopyridine: 3 cases. Spinal Cord In press.
15. Hayes KC. 4-Aminopyridine and spinal cord injury: a review. Restorative Neurology and Neuroscience 1994:6:259-70.
16. American Spinal Injury Association/International Medical Society of Paraplegia. International standards for neurological and functional classification of spinal cord injury, 1996.
17. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991;144:1202-18.
18. Segal JL. Clinical pharmacology of spinal cord injury. In: Woolsey RM, Young RR, eds. Diagnosis and management of disorders of the spinal cord. Philadelphia: WB Saunders, 1995:414-38.
19. Cheville AL, Kirshblum SC. Thyroid hormone changes in chronic spinal cord injury. J Spinal Cord Med 1995;18(4): 227-32.
20. Segal JL. Spinal cord injury: are interleukins a molecular link between neuronal damage and ensuing pathobiology? Perspect Biol Med 1993;36(2):222-40.
21. Segal JL, Gonzales E, Yousefi S, Jamshidipour L, Brunnemann SR. Circulating levels of IL-2r, ICAM-1, and IL-6 in spinal cord injuries. Arch Phys Med Rehabil 1997;78:44-7.
22. Segal JL, Milne N, Brunnemann SR. Gastric emptying is impaired in patients with spinal cord injury. Am J Gastroenterology 1995;90(3):466-70.
23. Mathias CJ, Frankel HL. Clinical manifestations of malfunctioning sympathetic mechanisms in tetraplegia. J Autonom Nerv Sys 1983;7:303-12.
24. Bannister R. Autonomic failure: a textbook of clinical disorders of the autonomie nervous system, 2nd ed. New York: Oxford University Press, 1988.
25. Inoue K, Miyake S, Kumashiro M. Power spectral analysis of heart rate variability in traumatic quadriplegic humans. Am J Physiol 1990;258:H1722-6.
26. Lehmann KG, Lane JG, Piepmeier JM, Batsford WP. Cardiovascular abnormalities accompanying acute spinal cord injury in humans: incidence, time course, and severity. J Am Coll Cardiol 1987;10:46-52.
27. Almenoff PL, Spungen AM, Lesser M, Bauman WA. Pulmonary function survey in spinal cord injury: influences of smoking and level and completeness of injury. Lung 1995;173:297-306.
28. Hayes KC, Hsieh JTC, Potter PJ, Wolfe DL, Delaney GA, Blight AR. Effects of induced hypothermia on somatosensory evoked potentials in patients with chronic spinal cord injury. Paraplegia 1993;31:730-41.
29. Davis JN. Spinal control. In: Campbell EJM, Agostoni E, Davis JN, eds. The respiratory muscles: mechanics and neural control, 2nd ed. Philadelphia: WB Saunders, 1970.
30. Bergofsky EE. Mechanism for respiratory insufficiency alter cervical cord injury: a source of alveolar hypoventilation. Ann Intern Med 1964;61: 435-47.